Big Gain For XTL Biopharmaceuticals Ltd.
Fri, Apr 04, 2025 at 07:55 PM
XTL Biopharmaceuticals Ltd. (XTLB:NASDAQ) shot up at $1.27, a gain of 35.1%. On Fri, Apr 04, 2025, XTLB:NASDAQ touched a New 2-Week Intraday Low of $0.92. From Fri, Mar 21, 2025, the stock recorded 40.00% Up Days and 54.55% Green Days
About XTL Biopharmaceuticals Ltd. (XTLB:NASDAQ)
XTL Biopharmaceuticals Ltd is engaged in the acquisition & development of pharmaceutical drugs for the treatment of unmet medical needs, currently for the treatment of schizophrenia and Hepatitis C. It has also developed a home therapeutic device.
Top 10 Gainers:
- IBO (Listing Market - NYSE Amex (IBO:NYSEMKT), 107.48%
- Antelope Enterprise Holdings Limited (AEHL:NASDAQ), 100.47%
- Tempo Automation Holdings Inc. (TMPO:NASDAQ), 84.62%
- CXApp Inc. Class A Common Stock (CXAI:NASDAQ), 76%
- Local Bounti Corporation (LOCL:NYSE), 68.44%
- XChange TEC.INC American Depositary Shares (XHG:NASDAQ), 49.5%
- Wellchange Holdings Company Limited (WCT:NASDAQ), 43.59%
- Maiden Holdings, Ltd. (MHLD:NASDAQ), 39.97%
- Forward Industries, Inc. (FORD:NASDAQ), 38.21%
- XTL Biopharmaceuticals Ltd. (XTLB:NASDAQ), 35.11%